Never has there been a more critical time to be a company delivering technologies and expertise that helps get new biologics and vaccines to patients faster. At Sartorius, we are that company.
Working in partnership with scientists, we help turn research discoveries into real-world medicines. Our bioprocessing equipment and services are called on every day to create biologics that treat debilitating diseases, including cancer and arthritis, and make affordable vaccines to prevent common infections. Global organizations turn to us when they need assistance accelerating production of new vaccines for pandemic viruses such as COVID-19, Ebola, H1N1, and SARS-CoV-2.
Sartorius is the partner of choice in bioprocessing because we offer innovative, groundbreaking solutions that life scientists demand. In upstream processing, our Ambr® multi-parallel, mini bioreactor systems allow rapid cell line selection and cell culture process development. With our Biostat® STR and Biostat® RM single-use bioreactors, scientists can achieve state-of-the-art seed train expansion and seamless scale-up for intensified processing. And to enable Bioprocess 4.0 smart manufacturing, there are advanced analytical tools, including BioPAT® Spectro, for Raman spectroscopy with Ambr® and Biostat STR® platforms coupled with SIMCA® and MODDE® data analytics software.
Through recent acquisitions, we have also expanded our downstream portfolio. We now provide reusable and single-use BioSMB multi-column chromatography systems for intensified purification of proteins and CIM® monolithic chromatography columns uniquely suited for purification of large biomolecules like mRNA and pDNA. Combining all these powerful tools in an end-to-end process makes it simpler for scientists to discover and develop drugs more rapidly, and safely speed up their biopharmaceutical manufacturing.
We understand that technology is only part of the solution for creating quality biologics, so we underpin ours with technical expertise and consultative support, giving researchers insights and a deeper understanding of the science that matters. We continually innovate in collaboration with industrial partners to optimize tools, operations, and processes for increasing productivity. This approach means we deliver real-world solutions to accelerate drug discovery, translational research, and time to clinic, making a significant impact on both affordability and accessibility of global healthcare.
Don’t just take our word for it. To see our innovations in action, take a look in any leading global biopharmaceutical company and CDMO. You’ll see our technology there, working hand in hand with the world’s brightest scientists, simplifying progress to develop and deliver medicines where and when they are needed most.
To find out how Sartorius can help you with simplifying progress, go to www.sartorius.com